Immunohistochemistry Market, By Product (Antibodies, Equipment, Kits, Reagents, Equipment, and Reagents, Kits), By Application (Drug Testing, Diagnostics, and Drug Testing), By End Use (Hospitals & Diagnostic Laboratories, and Research Institutes), and By Geography (NA, EU, APAC, LATAM and MEA) Analysis, Share, Trends, Size, & Forecast From 2020 2026
- Published Date: 2020-10-13
- Report ID: 1796
- Pages: 180
-
Format:
REPORT HIGHLIGHT
Immunohistochemistry market was valued at USD 1.77 billion by 2019, growing with 7.3% CAGR during the forecast period, 2020-2026
Market Dynamics
The introduction of novel technologically advanced immunohistochemistry solutions, growing prevalence of chronic diseases, and an increase in drug discovery are some of the major factors driving the growth of global immunohistochemistry market. In addition, growing healthcare expenditure and rising geriatric population are other factors fuelling market growth. According to statistics provided by the World Health Organization (WHO), the geriatric population all across the globe is estimated to reach around 2 billion by the end of 2050. Furthermore, increasing demand for personalized medicine and rapid growth in the emerging economies across Latin America and APAC are likely to create lucrative opportunities in the overall market during the forecast period. However, high setup costs and lack of specificity associated with immunohistochemistry techniques are expected to hinder the market growth in the coming future.
The antibodies segment accounted for the majority of share in the market in 2019 and is estimated to grow at a healthy rate during the forecast period. This is majorly owing to their extensive usage in immunohistochemistry procedures for drug testing and disease diagnosis. Antibody-related products such as antibody-drug conjugates, Fc-fusion proteins, & anti-body fragments and therapeutic monoclonal antibodies have become the chief product class in the overall market. Along with antibodies, the kit segment is projected to grow at the fastest pace by 2030 owing to the convenience and the compact nature offered by them. In addition, the kits used in immunohistochemistry consist of numerous products that are customized to fit the needs of the clinicians.
The diagnostics segment registered for the largest share in the industry in 2019 and is projected to experience a lucrative growth rate in the projected timeframe. The growth of this segment is attributed to the increase in the prevalence of chronic diseases and the increasing demand for an accurate diagnosis. Moreover, the increasing research & developments by pharmaceutical companies for novel drug development and discovery is estimated to raise demand for immunohistochemistry solutions. The PhRMA (Pharmaceutical Research & Manufacturers of America) invested around USD 79.6 billion in 2018 for the development and discovery of novel medicines.
Hospitals and diagnostic laboratories accounted for majority market share in 2019 majorly due to an increase in the incidence of chronic diseases coupled with the growing demand for disease diagnosis. Besides, technological advancements such as digital pathology and automated sample preparation have added considerable value. In addition, the growth in the number of clinical research laboratories and hospitals has also surged the demand for diagnostics, thereby boosting the segmental growth.
The North America region is estimated to hold a dominant position in terms of revenue and is anticipated to continue to lead the immunohistochemistry market during the period of forecast. The dominance of this region is attributed to the presence of well-established healthcare infrastructure coupled with the increasing adoption of immunohistochemistry in diagnostic centres and laboratories. The Asia Pacific market for immunohistochemistry is projected to witness the highest growth due to rapid economic development in emerging countries such as India, China, Singapore, and South Korea. In addition, the high prevalence of chronic diseases and a rapidly aging population are also anticipated to be prominent factors propelling the regional market growth.
Key players of the market include:
Merck KGaA
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Bio SB
Bio-Rad Laboratories, Inc.
Perkinelmer, Inc.
Cell Signaling Technology, Inc.
Abcam plc
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year 2015 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2026
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT
Kits
Reagents
o Fixation Reagents
o Stabilizers
o Organic Solvents
o Proteolytic Enzymes
o Histological Stains
o Blocking Sera and Reagents
o Chromogenic Substrates
o Diluents
Antibodies
o Primary Antibodies
o Secondary Antibodies
Equipment
o Tissue Processing Systems
o Slide Scanners
o Slide Staining Systems
o Tissue Microarrays
o Others
GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION
Diagnostics
o Diabetes Mellitus
o Cardiovascular Diseases
o Autoimmune Diseases
o Cancer
o Infectious Diseases
o Nephrological Diseases
Brain & Neurology
Drug Testing
Ophthalmology
Others
GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END USE
Research Institutes
Hospitals
Diagnostic Laboratories
Others
GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Singapore
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Rest of LATAM
Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Rest of MEA
TABLE OF CONTENT
1. IMMUNOHISTOCHEMISTRY MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Product
2.1.2. Market Snippet by End Use
2.1.3. Market Snippet by Application
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. IMMUNOHISTOCHEMISTRY KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. IMMUNOHISTOCHEMISTRY INDUSTRY STUDY
4.1. Porters Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
4.5. COVID-19 Impact Analysis
4.5.1. Pre-COVID-19 Impact Analysis
4.5.2. Post-COVID-19 Impact Analysis
5. IMMUNOHISTOCHEMISTRY MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. IMMUNOHISTOCHEMISTRY MARKET BY PRODUCT
6.1. Overview
6.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)
6.2. Kits
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3. Reagents
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.3. Fixation Reagents
6.3.3.1. Overview
6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.4. Stabilizers
6.3.4.1. Overview
6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.5. Organic Solvents
6.3.5.1. Overview
6.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.6. Proteolytic Enzymes
6.3.6.1. Overview
6.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.7. Histological Stains
6.3.7.1. Overview
6.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.8. Blocking Sera and Reagents
6.3.8.1. Overview
6.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.9. Chromogenic Substrates
6.3.9.1. Overview
6.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.10. Diluents
6.3.10.1. Overview
6.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.4. Antibodies
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.4.3. Primary Antibodies
6.4.3.1. Overview
6.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.4.4. Secondary Antibodies
6.4.4.1. Overview
6.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.5. Equipment
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.5.3. Tissue Processing Systems
6.5.3.1. Overview
6.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.5.4. Slide Scanners
6.5.4.1. Overview
6.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.5.5. Slide Staining Systems
6.5.5.1. Overview
6.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.5.6. Tissue Microarrays
6.5.6.1. Overview
6.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.5.7. Others
6.5.7.1. Overview
6.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7. IMMUNOHISTOCHEMISTRY MARKET BY END USE
7.1. Overview
7.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
7.2. Research Institutes
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.3. Hospitals
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.4. Diagnostic Laboratories
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.5. Others
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8. IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
8.2. Diagnostics
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.2.3. Diabetes Mellitus
8.2.3.1. Overview
8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.2.4. Cardiovascular Diseases
8.2.4.1. Overview
8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.2.5. Autoimmune Diseases
8.2.5.1. Overview
8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.2.6. Cancer
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.2.7. Infectious Diseases
8.2.7.1. Overview
8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.2.8. Nephrological Diseases
8.2.8.1. Overview
8.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.3. Brain & Neurology
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.4. Drug Testing
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.5. Ophthalmology
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.6. Others
8.6.1. Overview
8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9. IMMUNOHISTOCHEMISTRY MARKET BY GEOGRAPHY
9.1. Introduction
9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
9.2. North America
9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.2.4. North America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
9.2.5. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
9.2.6. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.2.7. U.S.
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.2.8. Canada
9.2.8.1. Overview
9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
9.3.5. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
9.3.6. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.3.7. Germany
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3.8. Italy
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3.9. United Kingdom
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3.10. France
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3.11. Rest of Europe
9.3.11.1. Overview
9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
9.4.6. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.4.7. India
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4.8. China
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4.9. Japan
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4.10. South Korea
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4.11. Rest of APAC
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
9.5.6. Latin America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.5.7. Brazil
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.5.8. Mexico
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.5.9. Argentina
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
9.6.6. Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.6.7. Saudi Arabia
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.6.8. United Arab Emirates
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10. KEY VENDOR ANALYSIS
10.1. Merck KGaA
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. F. Hoffmann-La Roche Ltd.
10.3. Danaher Corporation
10.4. Agilent Technologies, Inc.
10.5. Thermo Fisher Scientific, Inc.
10.6. Bio SB
10.7. Bio-Rad Laboratories, Inc.
10.8. Perkinelmer, Inc.
10.9. Cell Signaling Technology, Inc.
10.10. Abcam plc
11. 360 DEGREE ANALYSTVIEW
12. APPENDIX
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
